Readability user Testing also in Great Britain: Björn Becker comes to the DiapharmGruppe

Björn Becker coordinates English Readability user Testings with the DiapharmGruppe. (openPR) - Münster, 29 January 2007. Beate Beime & team of the DiapharmGruppe (diapharmgruppe.de) got Björn Becker as an additional coworker for international Lesbarkeitstests of package inserts on board. The diploma biologist will accompany the project management of Readability user Testings in Great Britain. On behalf the pharmaceutical industry Beate Beime & team accomplish the appropriate interview procedures since beginning of the year also in the united kingdom. “With it we could briefly increase the number of cycles during this very time-critical process before the permission distribution again”, describe business guide Beate Beime the reason for the expansion.

Since new medicaments may do November 2005 only then on the market are brought, if the comprehensibility of the package insert is guaranteed. Björn Becker will participate apart from the co-ordination of the studies necessary for it also in the production of the English-language final reports for module 1.3.4 of the permission dossier.

(approx. 990 indications)

Contact:
DiapharmGruppe
Pressestelle
Lingener STR. 12
D-48155 Münster

Ansprechpartnerin:
Nicole Sibbing

Tel.: +49 (0) 251 - 60935-17
nicole.sibbing@diapharmgruppe.de
www.diapharmgruppe.de


Agency contact:
CO-operate Wegener & Rieke GmbH
Zumsandestrasse 32
D-48145 Münster

Partner:
Christian Rieke

Tel.: +49 (0) 251 - 3222611
wort@co-operate.net
www.co-operate.net

Background information: DiapharmGruppe

For the optimal management of the Produktportfolios of medicaments and health products the DiapharmGruppe offers comprehensive and individual service and consulting services for enterprises within the health central range. The DiapharmGruppe with its team of approximately 60 qualified coworkers takes over when desired the strategic consultation, the management or the responsible person care of complete Produktportfolios. She gains a conversion of 10 millions euro. Societies of the DiapharmGruppe are Dr. Stefan Sandner GmbH (Pharmaceutical management & Portfolio Solutions), Dr. Kolkmann & Partner GmbH (Drug Registration & new Projects), Dr. Middeler et al. GmbH (Biotechnology & Medical DEVICE), Zentralinstitut medicament research GmbH (Analytics), Dr. Ebeling & Assoc. GmbH (Medical Affairs & Pharmacovigilance), Beate Beime & team (Clinical Research Coordination) as well as the HÄLSA Pharma GmbH (Responsible Manufacturer & Product release).

Dieser Artikel wurde veröffentlicht auf
OpenPR - http://openpr.de/news/117544/Readability-User-Testing-auch-in-Grossbritannien-Bjoern-Becker-kommt-zur-DiapharmGruppe.html